The symposium will feature innovative analytical technologies, expert talks on emerging trends in food, pharma and biopharma industries, and 1-to-1 interactions with our technical team.
Robustness and Ruggedness studies in Method development – Insights and Regulations
Being a reliable partner for your lab, we endeavor to continue providing you ROBUST analytical power to deliver HIGH EFFICIENCY to enhance your PRODUCTIVITY & PROFITABILITY.
Drugs of Abuse Automated Screening vs Manual Testing: What are the Benefits?
In this webinar, learn all about the trends of the Drugs of Abuse as a global problem and the essential factors to consider when starting Drugs of Abuse Testing.
Virtual Total Agilent Experience 2021 - Day 1
The symposium will feature innovative analytical technologies, expert talks on emerging trends in food, pharma and biopharma industries, and 1-to-1 interactions with our technical team.
High Resolution Size Exclusion Chromatography (SEC) Analysis of Intact Protein Biotherapeutics
This presentation will highlight comprehensive workflows for the analytical characterization of proteins using SEC, ProA-SEC 2D-LC and SEC-MS.
The power of (U)HPLC selectivity for diverse pharmaceutical methods
With so much attention paid over the years to column efficiency, it is important not forget about the power of selectivity.
Advances in Proteomics & Metabolomics 2021
This event features a collection of exclusive talks from leading scientists in the field, discussing their research and lending insights on the advances and challenges in this exciting space.
High-throughput screening symposium - Day 2
This is your chance to hear first-hand from industry leaders who are revolutionizing high-throughput quantitative analysis using Acoustic Ejection Mass Spectrometry (AEMS).
Automated workflow for mRNA sequencing by High Resolution LCMS
In this webinar we will discuss the use of an automated workflow which includes enzymatic digestion, high resolution LCMS analysis, and data analysis for mRNA sequencing.
Determination of Dimethylamine and Nitrite in Pharmaceuticals by Ion Chromatography to Assess the Likelihood of Nitrosamine Formation
The developed methods should be useful for the rapid screening and quantification of nitrite and DMA in pharmaceuticals and in-process sample to assess the likelihood of NDMA formation.
Related content
Development of a chiral liquid chromatography-tandem mass spectrometry for simultaneous determination of carnitine and acetylcarnitine enantiomers in food samples
Webinars LabRulezLCMS Week 40/2026
Atom by atom. Scientists reveal a new direction in medical diagnostics